Rigel Pharmaceuticals, Inc. (RIGL)
42.30
-0.18
(-0.42%)
USD |
NASDAQ |
Dec 16, 15:13
Rigel Pharmaceuticals Research and Development Expense (Annual): 23.38M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Eli Lilly & Co. | 10.99B |
| Catalyst Pharmaceuticals, Inc. | 12.65M |
| Amicus Therapeutics, Inc. | 109.36M |
| Nektar Therapeutics | 119.64M |
| Vertex Pharmaceuticals, Inc. | 3.630B |